News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,129 Results
Type
Article (5012)
Company Profile (17)
Press Release (220100)
Section
Business (82199)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120102)
Policy (7501)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14771)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3693)
Artificial intelligence (41)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (444)
Cardiovascular disease (22)
Career advice (393)
Career pathing (3)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16025)
Collaboration (167)
Compensation (168)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (104)
Cystic fibrosis (16)
Data (510)
Depression (5)
Diabetes (42)
Diagnostics (2040)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40806)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37750)
Executive appointments (311)
FDA (3925)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (184)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (108)
Government (411)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (49)
MASH (27)
Medical device (3858)
Medtech (3859)
Mergers & acquisitions (7424)
Metabolic disorders (121)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (339)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (921)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (29)
Peanut (5)
People (24586)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4775)
Phase II (6960)
Phase III (5547)
Pipeline (548)
Policy (9)
Postmarket research (625)
Preclinical (1868)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5112)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (27)
Series B (23)
Sickle cell disease (7)
Southern California (696)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (4)
United States (6997)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (49)
Last 7 days (137)
Last 30 days (743)
Last 365 days (10022)
2025 (2950)
2024 (11027)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9157)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11450)
Australia (1608)
California (1931)
Canada (696)
China (71)
Colorado (82)
Connecticut (91)
Delaware (29)
Europe (24503)
Florida (269)
Georgia (33)
Idaho (23)
Illinois (112)
India (6)
Indiana (64)
Iowa (1)
Japan (71)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (220)
Massachusetts (1545)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (22)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (557)
New Mexico (5)
New York (469)
North Carolina (326)
North Dakota (2)
Northern California (921)
Ohio (56)
Oklahoma (5)
Oregon (4)
Pennsylvania (342)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (696)
Tennessee (40)
Texas (227)
Utah (59)
Virginia (46)
Washington D.C. (9)
Washington State (174)
West Virginia (2)
Wisconsin (22)
225,129 Results for "iradimed corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
March 10, 2025
·
2 min read
Press Releases
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
January 30, 2025
·
2 min read
Press Releases
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
January 10, 2025
·
5 min read
Press Releases
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
·
5 min read
Deals
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global MarketTrading to commence effective on the market open June 14, 2024
IRADIMED CORPORATION announced today its common stock will uplist and commence trading on the Nasdaq Global Market, effective June 14, 2024, and will continue under the ticker symbol “IRMD.”
June 7, 2024
·
5 min read
Press Releases
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
December 10, 2024
·
6 min read
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company’s President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA.
March 13, 2024
·
2 min read
Business
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
IRADIMED CORPORATION announced that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024.
April 25, 2024
·
2 min read
Business
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
IRADIMED CORPORAtion announced today its financial results for the three months ended March 31, 2024.
May 2, 2024
·
14 min read
Business
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
IRADIMED CORPORATION today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023.
January 9, 2024
·
4 min read
1 of 22,513
Next
